tirzepatide effects on sleep (Zepbound) – A New Treatment for Obstructive Apnea and Obesity — BetterNight Tirzepatide is moving beyond weight

tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Fatty acid chain damage is particularly relevant for tirzepatide

doi: 10.2337/cd19-0100

We are available to assist with medical device QMS and regulatory considerations, including for LDTs

Following this spike, prescribing was relatively stable from September through November (0.01 percentage points per month), before increasing again from November to December (+0.04 points) and accelerating from December 2025 through February 2026 (+0.12 percentage points per month)